Association Between the MUC5B Promoter Polymorphism and Survival in Patients With Idiopathic Pulmonary Fibrosis

Anna L. Peljto, Yingze Zhang, Tasha E. Fingerlin, Shwu‐Fan Ma, Joe G. N. Garcia, Thomas J. Richards, Lori Silveira, Kathleen O. Lindell, Mark P. Steele, James E. Loyd,

JAMA · 2013 · 447 citations · 24 references

DOIFull text

Open access

Abstract

Among patients with IPF, a common risk polymorphism in MUC5B was significantly associated with improved survival. Further research is necessary to refine the risk estimates and to determine the clinical implications of these findings.

References

24